Aspirin on trial

May 8, 1998

A trial into the effects of aspirin on people at risk from heart disease or strokes is under way in Lanarkshire, which has the highest death rate from heart disease in Scotland.

Edinburgh University's department of public health sciences is coordinating the trial, backed by Pounds 1 million from the British Heart Foundation and the Scottish Office. Although aspirin is a well-established treatment for patients following a heart attack, it is not clear whether it also helps people considered at high risk of cardiovascular disease but with no symptoms. About 20,000 men and women over 50 with no symptoms will be screened for narrowing of the arteries, and about 3,300 with evidence of disease will be given either aspirin or a dummy pill over five years. This will determine whether future heart attacks and strokes can be prevented through early detection and treatment with low-dose aspirin.

You've reached your article limit

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 6 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments

Most Commented

Home secretary says government will support 'best' universities

Man handing microphone to audience member

Academic attainment of disadvantaged students can be improved if they can decide how they are assessed, study claims

Woman drinking tea from saucer

Plugging a multibillion-pound deficit exacerbated by June’s poll result may require ‘drastic measures’, analysts have warned

Italy's gold medallist

New measures to ensure universities are ‘not penalised’ for taking poorer students also outlined for next stage of TEF

Classroom, school

Higher education institutions can and should do more to influence education at a secondary school level, says Edward Peck